MedTrace Logo

Probiotics: Clinical Intervention Trial in Patients With Fibromyalgia

NCT02642289 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-03-14

No results posted yet for this study

Summary

This study evaluates the benefits of probiotics in patients with fibromyalgia syndrome.

Conditions

  • Fibromyalgia

Interventions

DIETARY_SUPPLEMENT

Lactobacillus acidophilus

Probiotic 5000, a commercial probiotic product provided by the company "Complementos Fitonutricionales, S.L."

DIETARY_SUPPLEMENT

Lactobacillus Rhamnosus GG ®

Ergyphilus confort, a commercial probiotic product provided by the nutritional supplements lab "Laboratorios Nutergia"

OTHER

Placebo

Innocuous substance

Sponsors & Collaborators

  • Pablo Román López

    lead OTHER

Principal Investigators

  • Angeles Fernandez, PhD · Universidad de Almeria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642289 on ClinicalTrials.gov